QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, July 4, 2007, 27(27):7268-7274; doi:10.1523/JNEUROSCI.1558-07.2007

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via ISI Web of Science (1) Citing Articles via Google Scholar Google Scholar Articles by Dziennis, S. Articles by Alkayed, N. J. Search for Related Content PubMed PubMed Citation Articles by Dziennis, S. Articles by Alkayed, N. J.

 Previous Article  |  Next Article 

Neurobiology of Disease
Role of Signal Transducer and Activator of Transcription-3 in Estradiol-Mediated Neuroprotection

Suzan Dziennis,¹ Taiping Jia,² Oline K. Rønnekleiv,^1,2 Patricia D. Hurn,^1,2 and Nabil J. Alkayed^1,2

Departments of ¹Anesthesiology and Peri-Operative Medicine and ²Physiology and Pharmacology, Oregon Health & Science University, Portland, Oregon 97239-3098

Correspondence should be addressed to Dr. Nabil J. Alkayed, Department of Anesthesiology and Peri-Operative Medicine, Oregon Health & Science University, 3181 S.W. Sam Jackson Park Road, UHS-2, Portland, OR 97239-3098. Email: alkayedn{at}ohsu.edu

Estradiol is protective in experimental cerebral ischemia, but the precise mechanisms remain unknown. Signal transducer and activator of transcription-3 (STAT3) is a transcription factor that is activated by estrogen, translocates to the nucleus, and induces the transcription of neuroprotective genes, such as bcl-2. We determined whether estradiol increases STAT3 activation in female rat brain after focal cerebral ischemia and whether STAT3 activation contributes to estradiol-mediated neuroprotection against ischemic brain injury. Ovariectomized (OVX) female rats with and without estradiol replacement were subjected to 2 h of middle cerebral artery occlusion (MCAO), and phosphorylated STAT3 (P-STAT3) and total STAT3 (T-STAT3) were quantified by Western blot analysis at 3 and 22 h of reperfusion. STAT3 activation was colocalized with neuronal and survival markers microtubule-associated protein 2 (MAP2) and Bcl-2 using immunohistochemistry. Infarct size was measured at 22 h after MCAO in estradiol-treated OVX animals in the presence and absence of STAT3 inhibitor cucurbitacin I (JSI-124) using 2,3,5-triphenyltetrazolium chloride staining. Estradiol increased P-STAT3 in the ischemic cortex cytosolic fraction at 3 h after MCAO without affecting T-STAT3. This was associated with increased P-STAT3 in the nuclear fraction, which remained elevated at 22 h after MCAO. The nuclear P-STAT3 colocalized with MAP2 and Bcl-2 within the peri-infarct zone. The P-STAT3 inhibitor JSI-124 abolished the protective effect of estradiol without affecting infarct size in untreated OVX rats. We conclude that estradiol increases STAT3 phosphorylation in neurons after MCAO and that STAT3 activation plays an important role in estradiol-mediated neuroprotection.

Key words: estrogen; STAT3; ischemia; neuroprotection; MCAO; JSI-124 (cucurbitacin I)

---

Received April 6, 2007; revised May 19, 2007; accepted May 28, 2007.

Correspondence should be addressed to Dr. Nabil J. Alkayed, Department of Anesthesiology and Peri-Operative Medicine, Oregon Health & Science University, 3181 S.W. Sam Jackson Park Road, UHS-2, Portland, OR 97239-3098. Email: alkayedn{at}ohsu.edu

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help